Comparative assessment of the effectiveness of anaesthesia for intravitreal bevacizumab injection.
LaHood
Benjamin R
BR
Sherwood
Derek
D
Suter
Antony
A
D000369:Aged, 80 and over; D000772:Anesthesia, Local / Q000379:methods*; D000779:Anesthetics, Local / Q000008:administration & dosage*; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000188:drug therapy; D058447:Eye Pain / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D058449:Intravitreal Injections; D008012:Lidocaine / Q000008:administration & dosage; D010147:Pain Measurement; D011343:Procaine / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D057135:Wet Macular Degeneration / Q000188:drug therapy
D000779:Anesthetics, Local; D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D011343:Procaine; D008012:Lidocaine; C005298:benoxinate